wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58714285-05F009B5-D337-48A5-83F1-505D57821B93
Q58714285-05F009B5-D337-48A5-83F1-505D57821B93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58714285-05F009B5-D337-48A5-83F1-505D57821B93
Structural basis for polymerase η-promoted resistance to the anticancer nucleoside analog cytarabine
P2860
Q58714285-05F009B5-D337-48A5-83F1-505D57821B93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58714285-05F009B5-D337-48A5-83F1-505D57821B93
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1f962584d6b5dfcc051aac9fca4d255368fb9667
P2860
A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3.